Assyro AI

FDA Orange Book · active-ingredient family

Halcinonide

Halcinonide is approved as 6 brand and 3 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:HALOG · NDA 017556

6

Brand (NDA)

3

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · cream, ointment, solution

ProductApplicantApplicationTEApproved
HALOGRLDSUN PHARM INDS INCNDA 017556ABApproved Prior to Jan 1, 1982
HALOGRLDWESTWOOD SQUIBBNDA 017818Approved Prior to Jan 1, 1982
HALOGRLDBRISTOL MYERS SQUIBBNDA 018125Approved Prior to Jan 1, 1982
HALOGRLDSUN PHARM INDS INCNDA 017824Approved Prior to Jan 1, 1982
HALOGRLDSUN PHARM INDS INCNDA 017823ATApproved Prior to Jan 1, 1982
HALOG-ESUN PHARM INDS INCNDA 018234Approved Prior to Jan 1, 1982

Generic (ANDA) products (3)

ProductApplicantApplicationTEApproved
HALCINONIDEENCUBEANDA 217671ATMay 29, 2024
HALCINONIDECHARTWELL RXANDA 214723ABSep 08, 2021
HALCINONIDEMYLANANDA 211027ABAug 12, 2019

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Halcinonide — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.